A Heather Eliassen

Author PubWeight™ 63.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 2004 3.28
2 A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol 2007 2.80
3 Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev 2010 2.09
4 Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Res Treat 2013 2.07
5 Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 2007 2.07
6 Teenage acne and cancer risk in US women: A prospective cohort study. Cancer 2015 2.05
7 Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res 2004 1.67
8 Determinants of plasma 25-hydroxyvitamin D and development of prediction models in three US cohorts. Br J Nutr 2012 1.59
9 Birthweight and body size throughout life in relation to sex hormones and prolactin concentrations in premenopausal women. Cancer Epidemiol Biomarkers Prev 2006 1.57
10 Body shape throughout life and correlations with IGFs and GH. Endocr Relat Cancer 2007 1.43
11 High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women. Circulation 2013 1.33
12 A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development. Cancer Res 2013 1.25
13 Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk. J Steroid Biochem Mol Biol 2007 1.25
14 Analgesic use and sex steroid hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2010 1.20
15 Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women. Cancer 2009 1.16
16 Within-person reproducibility of urinary bisphenol A and phthalate metabolites over a 1 to 3 year period among women in the Nurses' Health Studies: a prospective cohort study. Environ Health 2013 1.09
17 Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II. Breast Cancer Res 2013 1.08
18 Association of urinary concentrations of bisphenol A and phthalate metabolites with risk of type 2 diabetes: a prospective investigation in the Nurses' Health Study (NHS) and NHSII cohorts. Environ Health Perspect 2014 1.04
19 The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women. Cancer Epidemiol Biomarkers Prev 2006 1.04
20 Circulating sex steroids and breast cancer risk in premenopausal women. Horm Cancer 2010 1.03
21 Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop. J Natl Cancer Inst 2012 1.02
22 Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women - exercise and premenopausal hormones. Cancer Causes Control 2007 1.01
23 Associations between red meat intake and biomarkers of inflammation and glucose metabolism in women. Am J Clin Nutr 2013 1.00
24 Adult weight change and incidence of premenopausal breast cancer. Int J Cancer 2011 0.96
25 Adolescent physical activity in relation to breast cancer risk. Breast Cancer Res Treat 2014 0.95
26 β-Carotene 15,15'-monooxygenase 1 single nucleotide polymorphisms in relation to plasma carotenoid and retinol concentrations in women of European descent. Am J Clin Nutr 2012 0.93
27 Urinary concentrations of estrogens and estrogen metabolites and smoking in caucasian women. Cancer Epidemiol Biomarkers Prev 2012 0.92
28 Association between reproductive factors and urinary estrogens and estrogen metabolites in premenopausal women. Cancer Epidemiol Biomarkers Prev 2012 0.91
29 Premenopausal dietary fat in relation to pre- and post-menopausal breast cancer. Breast Cancer Res Treat 2014 0.90
30 Adolescent meat intake and breast cancer risk. Int J Cancer 2014 0.90
31 Plasma C-peptide, mammographic breast density, and risk of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 2013 0.90
32 Plasma florescent oxidation products and breast cancer risk: repeated measures in the Nurses' Health Study. Breast Cancer Res Treat 2013 0.89
33 Association between physical activity and urinary estrogens and estrogen metabolites in premenopausal women. J Clin Endocrinol Metab 2012 0.88
34 Urinary estrogens and estrogen metabolites and mammographic density in premenopausal women. Breast Cancer Res Treat 2012 0.88
35 Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer. Breast Cancer Res Treat 2014 0.87
36 The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women. Int J Cancer 2010 0.87
37 Energy balance, early life body size, and plasma prolactin levels in postmenopausal women. Cancer Causes Control 2008 0.87
38 Plasma free 25-hydroxyvitamin D, vitamin D binding protein, and risk of breast cancer in the Nurses' Health Study II. Cancer Causes Control 2014 0.86
39 Food predictors of plasma carotenoids. Nutrients 2013 0.85
40 Urinary melatonin concentration and the risk of breast cancer in Nurses' Health Study II. Am J Epidemiol 2015 0.84
41 Dietary fat intake in relation to lethal breast cancer in two large prospective cohort studies. Breast Cancer Res Treat 2014 0.83
42 Analgesic use in relation to sex hormone and prolactin concentrations in premenopausal women. Cancer Causes Control 2013 0.82
43 Body size in relation to urinary estrogens and estrogen metabolites (EM) among premenopausal women during the luteal phase. Horm Cancer 2012 0.81
44 Associations between dietary acrylamide intake and plasma sex hormone levels. Cancer Epidemiol Biomarkers Prev 2013 0.81
45 Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women. Breast Cancer Res Treat 2015 0.81
46 Plasma carotenoid- and retinol-weighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 2013 0.81
47 Premenopausal plasma carotenoids, fluorescent oxidation products, and subsequent breast cancer risk in the nurses' health studies. Breast Cancer Res Treat 2015 0.81
48 Plasma enterolactone and breast cancer risk in the Nurses' Health Study II. Breast Cancer Res Treat 2013 0.79
49 The relationship between bilateral oophorectomy and plasma hormone levels in postmenopausal women. Horm Cancer 2014 0.79
50 Population Attributable Risk of Modifiable and Nonmodifiable Breast Cancer Risk Factors in Postmenopausal Breast Cancer. Am J Epidemiol 2016 0.78
51 Physical activity and risk of endometrial adenocarcinoma in the Nurses' Health Study. Int J Cancer 2013 0.78
52 Analgesic use and patterns of estrogen metabolism in premenopausal women. Horm Cancer 2014 0.78
53 Laparoscopically Confirmed Endometriosis and Breast Cancer in the Nurses' Health Study II. Obstet Gynecol 2016 0.77
54 Stability and Reproducibility of the Measurement of Plasma Nitrate in Large Epidemiologic Studies. N Am J Med Sci (Boston) 2013 0.77
55 Intake of vitamins A, C, and E and folate and the risk of ovarian cancer in a pooled analysis of 10 cohort studies. Cancer Causes Control 2015 0.76
56 Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II. Cancer Epidemiol Biomarkers Prev 2014 0.76
57 Association between global biomarkers of oxidative stress and hip fracture in postmenopausal women: a prospective study. J Bone Miner Res 2014 0.76
58 ROTATING NIGHT SHIFT WORK AND RISK OF BREAST CANCER IN THE NURSES' HEALTH STUDIES. Am J Epidemiol 2017 0.75
59 Menopause and postmenopausal hormone therapy and risk of hearing loss. Menopause 2017 0.75
60 Cigarette Smoking and Risk of Early Natural Menopause. Am J Epidemiol 2017 0.75
61 Alcohol consumption and breast cancer risk by family history of breast cancer and folate intake in younger women. Am J Epidemiol 2017 0.75